Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000815947 | SCV000956428 | likely benign | Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome | 2024-11-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002534880 | SCV003735680 | likely benign | Inborn genetic diseases | 2022-03-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004705783 | SCV005227253 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ce |
RCV004705783 | SCV005434447 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | GLI3: BP4 |